Boatwright Drug Co Long Term Care Pharmacy Location: 7899 Leroy Boatwright St, Millington, Tennessee 38053 Phone: (901) 872-2214 |
Kroger Pharmacy #393 Durable Medical Equipment & Medical Supplies Location: 8039 Highway 51 North, Millington, Tennessee 38053 Phone: (901) 872-0167 |
Walmart Pharmacy #10-0094 Durable Medical Equipment & Medical Supplies Location: 8445 Hwy 51 North, Millington, Tennessee 38053 Phone: (901) 872-8858 |
Walgreens #7792 Durable Medical Equipment & Medical Supplies Location: 7994 Us Highway 51 N, Millington, Tennessee 38053 Phone: (901) 873-3373 |
West Tennessee Eye, Plc Medicare Supplier Location: 8120 Us Highway 51 N, Millington, Tennessee 38053 Phone: (901) 872-2020 |
News Archive
New results from a global survey of over 150 people living with idiopathic pulmonary fibrosis (IPF), a life-threatening rare lung disease, demonstrate that while many patients were involved in treatment decisions, opportunities exist to improve the level of dialogue between patients and healthcare professionals.
MEDTOX Scientific, Inc. today announced fourth quarter and year-end results for the periods ended December 31, 2010.
Even as Montana begins a gradual easing of stay-at-home restrictions intended to curb the spread of the coronavirus, the political schism it highlighted is creating reverberations in one community in the northwestern corner of the state.
For migraine sufferers with obesity, losing weight can decrease headaches and improve quality of life, researchers from Italy and the United States report.
Boehringer Ingelheim will present a pooled analysis of new data from the Phase 3 UniTinA-asthma® program at the European Respiratory Society (ERS) Annual Congress 2013 in Barcelona. The data from the individual MezzoTinA-asthma® Phase 3 studies (NCT01340209 and NCT00565266), from which the pooled data are derived, show the addition of tiotropium delivered via the Respimat® inhaler to medium-dose maintenance inhaled corticosteroid (ICS) therapy (defined as 400-800 µg budesonide/day or equivalent) improved lung function and provided sustained bronchodilation over 24 hours in patients with moderate asthma and airflow limitation. Tiotropium is being investigated to determine the medicine's efficacy in treating asthma patients and is not currently approved for this indication.
› Verified 8 days ago